Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

While you may be more familiar with brand names such as Ozempic or Wegovy, these drugs are known as glucagon-like peptide-1 (GLP-1) agonists in the medical world. Eli Lilly ( LLY -0.50%) has emerged ...

Volume & Open Interest Trends In terms of liquidity and interest, the mean open interest for Eli Lilly options trades today is 402.8 with a total volume of 21,398.00. In the following chart ...

Eli Lilly (LLY) is one of the stocks most watched ... along with three other factors related to earnings estimates, Lilly is rated Zacks Rank #3 (Hold). The chart below shows the evolution of the ...

Eli Lilly stock has advanced more than 200% over the past three years thanks to the company’s dominance in the weight loss drug market. Lilly may face more competitors down the road in this high ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Right now, Lilly trades at a forward price to earnings (P/E) multiple of 36. As the chart below illustrates, Lilly's current forward P/E is roughly 40% lower today than it was just a year ago.

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.